Netarsudil Mesylate 200 micrograms/ml eye drops, solution

Netarsudil, a Rho kinase inhibitor, is believed to reduce IOP by increasing outflow of aqueous humor. Studies in animal and man suggest that the main mechanism of action is increased trabecular outflow. These studies also suggest that netarsudil lowers IOP by reducing episcleral venous pressure. 

Netasudil Mesylate is indicated for the reduction of elevated intraocular pressure (IOP) in adult patients with primary open-angle glaucoma or ocular hypertension.